Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Placebo-Controlled, Dose-Ranging Study of Quadrivalent HPV Virus-Like Particle (VLP) Vaccine in 16- to 23-Year-Old Women
Brief Summary: This study was conducted in 2 parts. Part A was a randomized, double-blind, placebo-controlled, multicenter, sequential dose-escalating evaluation. Part B was a randomized, double-blind (operating under in-house blinding procedures), placebo-controlled, multicenter, dose-ranging study.


Options:
A: Arm Label: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine; Type: EXPERIMENTAL; Interventions: Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20 | Arm Label: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40; Type: EXPERIMENTAL; Interventions: Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40 | Arm Label: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80; Type: EXPERIMENTAL; Interventions: Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80 | Arm Label: Placebo (mcg) (Aluminum Adjuvant) 225; Type: EXPERIMENTAL; Interventions: Biological: Placebo (mcg) (Aluminum Adjuvant)225 | Arm Label: Placebo (mcg) (Aluminum Adjuvant) 450; Type: EXPERIMENTAL; Interventions: Biological: Placebo (mcg) (Aluminum Adjuvant) 450 | Intervention Type: BIOLOGICAL; Name: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20; Assigned to Arm(s): Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine | Intervention Type: BIOLOGICAL; Name: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40; Assigned to Arm(s): Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40 | Intervention Type: BIOLOGICAL; Name: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80; Assigned to Arm(s): Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80 | Intervention Type: BIOLOGICAL; Name: Placebo (mcg) (Aluminum Adjuvant)225; Assigned to Arm(s): Placebo (mcg) (Aluminum Adjuvant) 225 | Intervention Type: BIOLOGICAL; Name: Placebo (mcg) (Aluminum Adjuvant) 450; Assigned to Arm(s): Placebo (mcg) (Aluminum Adjuvant) 450
B: Arm Label: 9- to 15-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 2); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 3); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Males (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 16- to 26-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Intervention Type: BIOLOGICAL; Name: V503; Assigned to Arm(s): 16- to 26-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 2), 9- to 15-Year-Old Females (Lot 3), 9- to 15-Year-Old Males (Lot 1)
C: Arm Label: Tetravalent Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: Tetravalent Vaccine | Arm Label: Bivalent Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: Bivalent Vaccines | Intervention Type: BIOLOGICAL; Name: Bivalent Vaccines; Assigned to Arm(s): Bivalent Vaccine | Intervention Type: BIOLOGICAL; Name: Tetravalent Vaccine; Assigned to Arm(s): Tetravalent Vaccine
D: Arm Label: 16-26 year olds 3 doses HPV Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV (Human Papillomavirus) Vaccine | Arm Label: 3 dose 9-13 HPV Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV (Human Papillomavirus) Vaccine | Arm Label: 2 dose 9-13 yrs HPV Vaccine; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV (Human Papillomavirus) Vaccine | Intervention Type: BIOLOGICAL; Name: HPV (Human Papillomavirus) Vaccine; Assigned to Arm(s): 16-26 year olds 3 doses HPV Vaccine, 2 dose 9-13 yrs HPV Vaccine, 3 dose 9-13 HPV Vaccine

Answer: A